Opera singers are at a greater risk of developing reflux disease because of their effort to sing but are reluctant to undergo invasive diagnostic tests for fear of damaging their vocal cords. Peptest has been identified as a useful tool for diagnosing reflux in opera singers.
Peptest has been described as a ‘good first-line diagnostic procedure to use in reflux sufferers to confirm the presence of reflux’ in the Journal of Gastrointestinal and Liver Diseases.
A new UK study with more than 1,000 patients has demonstrated how Peptest can be used to diagnose laryngopharyngeal reflux (LPR) in hospitals, voice clinics and GP surgeries.
Let’s introduce you to a key member of the RD Biomed and Peptest team… Jeanine Fisher. Jeanine joined our company in 2006 and can usually be found in the Peptest laboratories at Castle Hill Hospital in Hull.
A new study ‘Cashew gum, a biopolymer, topically protects oesophageal mucosa in nonerosive reﬂux disease: A promising translational study’ has looked at whether cashew gum can help with nonerosive reflux disease (NERD).
Peptest – a non-invasive device for diagnosing reflux disease – has been approved by Chinese health authorities and officially launched in China.
Peptest has been described as a 'cost‐effective, non-invasive measurement tool’ to assist office‐based diagnosis of laryngopharangeal reflux disease (LPR) in a new research paper. The study, published in The Laryngoscope – the monthly peer-reviewed medical journal in...
The Peptest team headed to the Czech Republic in October to take part in the second annual ‘Peptest Day’ hosted by Imedex.
Doctors in the UK have been told to stop prescribing four types of a heartburn medication called Zantac or ranitidine as a ‘precautionary measure’.
Alginate, a type of fibre found in seaweed, has been used to help with the symptoms of reflux disease for many years. Alginates naturally occur as structural polysaccharides in brown algae and have a unique mode of action, producing a ‘raft’.
Information on a UK multicentre study evaluating the use of Peptest for patients with laryngopharyngeal reflux (LPR) will be presented at a world-class laryngology conference this month.
Peptest has been officially registered as a product with the Chinese National Medical Products Administration (NMPA) as announced in Beijing this September.